REGENSBURG, Germany, and OXFORD, England–(BUSINESS WIRE)–October 28, 2021– Leading NMR diagnostics company numares AG today announced that the company signed an exclusive licence agreement with Oxford University Innovation. This allows numares to translate and exploit preliminary work of Oxford University on Multiple Sclerosis (MS) biomarkers for the development of an urgently needed in-vitro diagnostics (IVD) […]
Home »
numares’ Novel GFR Equation Allows Accurate Assessment of Renal Insufficiency in Proof of Concept
BOSTON, Mass. & REGENSBURG, Germany–(BUSINESS WIRE)–February 25, 2021– Leading NMR diagnostics company numares recently published data showing that its novel, multi-marker approach to assess kidney function allowed for a more precise estimation of glomerular filtration rate (GFR) by a simple serum test. Named GFRNMR, the test provided metabolic characterization of renal dysfunction, by evaluating a […]